172 related articles for article (PubMed ID: 3184271)
21. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: induction of neutralizing antibody.
Ford CM; Arp J; Palker TJ; King EE; Dekaban GA
Virology; 1992 Nov; 191(1):448-53. PubMed ID: 1413516
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of various virulence tests with low virulence vaccinia virus in mice.
Ludvíková V; Kutinová L; Simonová V; Otavová M
Biologicals; 1994 Jun; 22(2):187-90. PubMed ID: 7917234
[TBL] [Abstract][Full Text] [Related]
24. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice.
Grigorieva IM; Grigoriev VG; Zakharova LG; Pashvykina GV; Shevlyagin VY; Altstein AD
Immunol Lett; 1993 Jun; 36(3):267-71. PubMed ID: 8370598
[TBL] [Abstract][Full Text] [Related]
26. Immunisation of cattle with a recombinant vaccinia vector expressing the haemagglutinin gene of rinderpest virus.
Yamanouchi K; Inui K; Sugimoto M; Asano K; Nishimaki F; Kitching RP; Takamatsu H; Barrett T
Vet Rec; 1993 Feb; 132(7):152-6. PubMed ID: 8456545
[TBL] [Abstract][Full Text] [Related]
27. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
Gurt I; Abdalrhman I; Katz E
Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
[TBL] [Abstract][Full Text] [Related]
28. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
[TBL] [Abstract][Full Text] [Related]
29. Recombinant vaccinia virus: immunization against multiple pathogens.
Perkus ME; Piccini A; Lipinskas BR; Paoletti E
Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
[TBL] [Abstract][Full Text] [Related]
30. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
Flexner C; Hügin A; Moss B
Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219
[TBL] [Abstract][Full Text] [Related]
31. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
[TBL] [Abstract][Full Text] [Related]
33. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
34. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
[TBL] [Abstract][Full Text] [Related]
35. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW
J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707
[TBL] [Abstract][Full Text] [Related]
36. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
[TBL] [Abstract][Full Text] [Related]
37. Studies of TGEV spike protein gp195 expressed in E. coli and by a TGE-vaccinia virus recombinant.
Hu S; Bruszewski J; Smalling R; Browne JK
Adv Exp Med Biol; 1985; 185():63-82. PubMed ID: 3000150
[TBL] [Abstract][Full Text] [Related]
38. [Design of a recombinant strain of the vaccinia virus containing an expressible gene for influenza A virus hemagglutinin].
Gibadulin RA; Lazarenko AA; Iuferov VP; Lideman LF; Denisova GF
Vopr Virusol; 1988; 33(3):275-8. PubMed ID: 3176425
[TBL] [Abstract][Full Text] [Related]
39. Development of heat-stable recombinant rinderpest vaccine.
Tsukiyama K; Yoshikawa Y; Kamata H; Imaoka K; Asano K; Funahashi S; Maruyama T; Shida H; Sugimoto M; Yamanouchi K
Arch Virol; 1989; 107(3-4):225-35. PubMed ID: 2818208
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
